Healthcare Technology Report May 29, 2024

The U.S. FDA, Environmental Protection Agency, and Department of Agriculture have responded to President Biden’s call by unveiling a comprehensive plan to overhaul biotech regulations. Prompted by Executive Order 14081, issued in September 2022, the plan aims to modernize regulations surrounding the development and manufacture of biotech products, from industrial goods to CRISPR technologies. Stakeholder feedback, including input from industry groups and public commentary, has shaped the plan, highlighting the need for clarity, synchronization, and updates to existing regulations.

Future policy initiatives outlined in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, HHS, Pharma / Biotech, Regulations
GSK Wagers $80M on a Tech Platform and Parkinson’s Drug from Flagship-Founded Vesalius
Halozyme Makes Unsolicited €2B Takeover Bid for Drug R&D Services Firm Evotec
An Update on Therapeutics for COVID-19
Life Sciences: Transforming Batch Management With Innovative Tech
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations

Share This Article